Cardiovascular disease is the leading cause of death for people with serious mental illness. A clinical decision support tool produced a significant relative reduction in total modifiable cardiovascular risk for intervention patients versus controls.
In this report, a case of nocturia caused by expired escitalopram in a patient with depressive symptoms is discussed.
Tendler et al argue that, in considering transcranial magnetic stimulation (TMS) treatment, providers should refer to recent guidelines and literature reports instead of universally excluding…
ABSTRACT Psychosis is a psychiatric emergency that affects up to 1 in 500 women postpartum and can result from various etiologies. We present a case…
Hypertensive disorders of pregnancy (HDP) are a major complication. In this study, the risk of HDP with SNRIs (9.5%) was significantly higher than with SSRIs…
This study assessed the prevalence and odds of bullying victimization among US children with 1 or more mental, emotional, developmental, or behavioral problems.
ABSTRACT Objective: Individuals with major depressive disorder (MDD) and bipolar disorder (BD) are at increased risk of suicide. The objective of this study was to…
Improved identification and integrated clinical management of sociodemographic, military, and health risk factors may help mitigate disability risk and promote the maintenance of functional capacity…
DBS targeting the subcallosal cingulate gyrus to treat depressive symptoms resulted in response and remission rates of 75% and 62.5%.
The new dual agonist drug, DA5-CH, shows promise in Parkinson’s disease trials, outperforming diabetes drug Ozempic in a rat model.
Transient functional brain changes with psilocybin therapy resemble the “brain reset” phenomenon and may serve as the putative predictors of psilocybin antidepressant response.
